Applied Genetic Technologies Corporation

NasdaqGM:AGTC Stock Report

Market Cap: US$12.6m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Applied Genetic Technologies Balance Sheet Health

Financial Health criteria checks 3/6

Key information

92.6%

Debt to equity ratio

US$16.34m

Debt

Interest coverage ration/a
CashUS$34.24m
EquityUS$17.65m
Total liabilitiesUS$39.69m
Total assetsUS$57.33m

Recent financial health updates

Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

May 21
Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

Jan 06
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

Recent updates

AGTC receives positive feedback from FDA for manufacturing facility

Jul 26

Applied Genetic Technologies proposes stock offering to fund clinical trials

Jul 12

Applied Genetic Tech: A Speculative Biotech With Potential To Turn Corner In 2022

Jan 12

An Assessment Of Applied Genetic Technologies Corporation

Dec 14

Applied Genetic Technologies: Weak Early Clinical Ocular Results Highlight Increased Risk

Jul 15

Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

May 21
Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

Applied Genetic trades lower after announcing the departure of chief scientific officer

Apr 26

What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?

Feb 05
What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?

Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

Jan 06
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Dec 11
What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Interim data on gene therapy for vision loss disorder fails to lift Applied Genetic

Nov 11

Financial Position Analysis

Short Term Liabilities: AGTC's short term assets ($37.2M) exceed its short term liabilities ($26.6M).

Long Term Liabilities: AGTC's short term assets ($37.2M) exceed its long term liabilities ($13.1M).


Debt to Equity History and Analysis

Debt Level: AGTC has more cash than its total debt.

Reducing Debt: Insufficient data to determine if AGTC's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AGTC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: AGTC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.4% each year


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.